Open original FDA record ↗Recall record
- FDA identifier
- Z-0547-2021
- Company in FDA record
- Randox Laboratories Ltd.
- FDA record creation date
- Dec 8, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Failing to meet the linearity performance claims quoted on the kit inserts-The linearity is reduced by approximately -30% for Serum/ Plasma and -50% for Urine
Source facts
- Action
- Randox issued Urgent Medical Device Correction letter via e-mail to US Customers on 13 November 2020 stating reason for recall, health risk and action to take: Discontinue use of and discard any of the above immediately. " Review your reagent inventory of these products and assess your laboratories needs for reimbursement for discarded inventory. " Review results generated with the affected batches in line with the clinical profile of the patient. " Discuss the contents of this notice with your Medical Director. " Complete and return the response form 12187-QA to technical. services@randox.com within five working days. Questions or concerns, please contact Randox Technical Services.
- Initiated
- 2020-11-13
- Root cause
- Under Investigation by firm
- Terminated
- 2021-04-01
- Distribution
- US Nationwide distribution in the states of GA, NJ.
- Recall number
- Z-0547-2021
- Recall status
- Terminated
- CDRH record ID
- 184629
- FDA record created
- 2020-12-08
- Recall event number
- 86827